WEAV:NYE-Weave Communications Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 10.24

Change

+0.02 (+0.20)%

Market Cap

USD 0.73B

Volume

0.25M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-30 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

N/A

USD 10.78B
DOCS Doximity Inc

N/A

USD 6.81B
MPLN MultiPlan Corporation

N/A

USD 0.16B
AMWL American Well Corp

N/A

USD 0.12B
OWLT Owlet Inc

N/A

USD 0.05B
PHR Phreesia Inc

N/A

N/A
VEEV Veeva Systems Inc Class A

N/A

N/A
FOXO FOXO Technologies Inc.

N/A

N/A
EVH Evolent Health Inc

N/A

N/A
TDOC Teladoc Inc

N/A

N/A

ETFs Containing WEAV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.72% 70% C- 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.72% 70% C- 12% F
Trailing 12 Months  
Capital Gain -11.42% 80% B- 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.42% 80% B- 15% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 33.11% 91% A- 91% A-
Dividend Return 33.11% 91% A- 90% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 69.94% 36% F 11% F
Risk Adjusted Return 47.34% 91% A- 68% D+
Market Capitalization 0.73B 67% D+ 53% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector